Re: Generic names in prescriptions: Exercise

[Guest guest]

Hi,

Great news flowing from Sri Lanka. May we the better sense prevail

on Indian counterparts who seem to be more busy in replacing the

heads of medical institutions, controlling the prices of medicines

which are either not produced or do not sell much, and press

publicity.

Srilankan initiative reminds me that Govt of India after

independence had appointed Hathi Commission for weeding out

irrational medicines from the country. Historical record shows that

the commission's report kept gathering dust and it was adopted by

our neighbouring country ! Can the young NetRUMians believe that ?

Exercise for the young members to dig more on this and post on

NetRUM, before the next discussion picks up.

Vijay Thawani

> >

> > > Copied as fair use from E Drug, post from Shazia,

> > > our member.

> > > Vijay Thawani

> > > Groupie

> > >

> >

> ----------------------------------------------------------

> > >

> > > E-DRUG: Use of generic or brand names in

> > > prescriptions (6)

> > > -----------------------------------------------

> > >

> > > Generic medicine policies of the developing

> > > countries reflects

> > > disparity in terms of effective execution

> > >

> > > Although a tailor-made regulatory framework in

> > some

> > > developing

> > > countries to galvanize the registration procedure

> > > for generics along

> > > with a minimal amount of registration fee is

> > > evident, the flunking

> > > of any generic medicine policy is in fact

> > interplay

> > > of many

> > > composite factors.

> > >

> > > Discredited status of generics in the eyes of

> > > prescriber makes them

> > > as scarce as hen's teeth in prescription. The

> > image

> > > of generic drugs

> > > whether in the eyes of prescriber or dispenser is

> > > built on negative

> > > preconceived notions about their efficacy and

> > safety

> > > thus owing to

> > > deficient or expensive infrastructure facilities

> > > which demonstrates

> > > their quality.

> > >

> > > Even in certain instances consumer being aware of

> > > generic medicines

> > > preferably opts for brand drugs considering them

> > to

> > > be more potent,

> > > safe and efficacious as compared to their generic

> > > counterparts.

> > >

> > > In developing countries with changing dynamics of

> > > economies

> > > consumers although procuring medicines on sheer

> > > out-of-pocket basis

> > > are not deterred to pick out high-priced innovator

> > > brands.

> > >

> > > Generic penetration varies in the developing

> > world

> > > and the sale of

> > > generics are growing in all the major markets but

> > > the proper

> > > domestic availability of quality generics and

> > > quality use is still a

> > > question mark.

> > >

> > > The National Health Policy of India (2002)

> > > emphasizes the need for

> > > the use of generic drugs as a prerequisite for

> > > cost-effective public

> > > health care but the availability in the public

> > > sector is still not

> > > proper.

> > >

> > > Innovator products were priced 90% higher than

> > the

> > > lowest price

> > > generics in Pakistan. The National Drug Policy has

> > > failed to achieve

> > > its public health objectives; although clearly

> > > highlighting proper

> > > use of generics. In the past generics have been

> > > knocked down due to

> > > perceived flaws such as quality, safety and

> > > efficacy.

> > >

> > > In developing countries just and upright health

> > > system can only be

> > > acquired through groundbreaking measures. Brazil

> > is

> > > one such

> > > example. Brazil exhibits tenacious commitment to

> > > public health

> > > issues. Brazilians successfully retained this

> > > steadfast fixity of

> > > purpose of defending their health system despite

> > all

> > > odds. In 1999

> > > Brazil instituted its generic medicine policy and

> > > therefore generics

> > > instantaneously gripped the Brazilian

> > pharmaceutical

> > > market.

> > > Promulgation of the legislation and sensitization

> > of

> > > the public by

> > > means of mass media coverage as well as active

> > > participation of the

> > > government were underlying components of its

> > > success. Thus

> > > Brazilians purchase medicines at more affordable

> > > prices.

> > >

> > > Why can't Brazil be a model in terms of access

> > and

> > > affordability of

> > > medicines in Indo-Pakistan subcontinent?

> > >

> > > Shazia Jamshed

> > > PhD Scholar

> > > Social and Administrative Pharmacy

> > > School of Pharmaceutical Sciences

> > > Universiti Sains Malaysia

> > > Penang

> > > Malaysia

> > > shazia jamshed <shazia_12@...>

> > >

> > > _______________________________________________

> > > Post message: e-drug@...

> > > Subscribe: e-drug-join@...

> > > Unsubscribe: e-drug-leave@...

> > > Help: e-drug-owner@...

> > > Info & archives:

> > > http://list.healthnet.org/mailman/listinfo/e-drug

> > >

> > >

> > >

> > >

> > >

> > >

> >

> >

> >

> >

> >

>

_____________________________________________________________________

_______________

> > Looking for last minute shopping deals?

> > Find them fast with Search.

> >

> http://tools.search./newsearch/category.php?

category=shopping

> >

>

>

>

>

_____________________________________________________________________

_______________

> Looking for last minute shopping deals?

> Find them fast with Search.

http://tools.search./newsearch/category.php?

category=shopping

>